Inhibitor Incidence in Haemophilia a Under Exclusive Use of a Third-Generation Recombinant Factor VIII Concentrate: Results of the HEMFIL Cohort Study

British Journal of Haematology - United Kingdom
doi 10.1111/bjh.15728
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Immune Status of Patients With Haemophilia a Before Exposure to Factor VIII: First Results From the HEMFIL Study

British Journal of Haematology
Hematology
2017English

Highly Purified Porcine Factor VIII in Haemophilia a With Inhibitors to Factor VIII

BMJ
1981English

Antithrombin Concentrate Use in Children: A Multicenter Cohort Study

Journal of Pediatrics
Child HealthPediatricsPerinatology
2013English

Multicenter Clinical Study of a Highly Purified Porcine Factor VIII Concentrate [MTI-9002 (Hyate: C)] in Hemophilia a Patients With Inhibitor

Japanese Journal of Thrombosis and Hemostasis
1991English

Identification of a Novel Mutation in the Factor VIII Gene Causing Severe Haemophilia A

BMC Hematology
HematologyMolecular Biology
2018English

Long-Term Treatment Course of a Patient With Mild Haemophilia a Who Developed a High Titre Factor VIII Inhibitor

Haemophilia
MedicineGeneticsHematology
2014English

Psy139 - Current Use of Factor Viii Products in Children and Adolescents With Moderate or Severe Haemophilia A

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Diagnosis of Haemophilia: Use of an Artificial Factor-Viii-Deficient Human Plasma System

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1967English

AMulticenter Clinical Study of Recombinant Factor VIII (BL-160) in Hemophilia a Patients

Japanese Journal of Thrombosis and Hemostasis
1993English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy